A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages-Reference-Cited by-同舟云学术

A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages

Published:2020-07 Issue: Volume:257 Page:112873
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Yu Luyao,Jia Dan,Feng Kunmiao,Sun Xiaolei,Xu Wumu,Ding Luying,Xin Hailiang,Qin Luping,Han Ting

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference28 articles.

1. The molecular understanding of osteoclast differentiation;Asagiri;Bone,2007

2. Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis;Cao;J. Biol. Chem.,2013

3. Evolving concepts of rheumatoid arthritis;Firestein;Nature,2003

4. Primary human bone marrow adipocytes support TNF-alpha-induced osteoclast differentiation and function through RANKL expression;Goto;Cytokine,2011

5. Compositions and in vitro anticancer activities of the leaf and fruit oils of Litsea cubeba from Taiwan;Ho;Nat. Prod. Commun.,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genus Litsea: A comprehensive review of traditional uses, phytochemistry, pharmacological activities and other studies;Journal of Ethnopharmacology;2024-11

2. Kemik Sağlığında Bağırsak Mikrobiyotasının Etkisi: Güncel Yaklaşımlar;İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi;2024-08-31

3. Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents;RSC Medicinal Chemistry;2024

4. Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach;Drug Design, Development and Therapy;2023-09

5. Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds;Frontiers in Pharmacology;2022-11-09